913277-48-2Relevant academic research and scientific papers
Aminopyrazine CB1 receptor inverse agonists
Wustrow, David J.,Maynard, George D.,Yuan, Jun,Zhao, He,Mao, Jianmin,Guo, Qin,Kershaw, Mark,Hammer, Jack,Brodbeck, Robbin M.,Near, Kristen E.,Zhou, Dan,Beers, David S.,Chenard, Bertrand L.,Krause, James E.,Hutchison, Alan J.
scheme or table, p. 3376 - 3381 (2009/04/11)
A series of 5,6-diaryl-2-amino-pyrazines were prepared and found to have antagonist-like properties at the CB1 receptor. Subsequent SAR studies optimized both receptor potency and drug-like properties including solubility and Cytochrome-P450 inhibition potential. Optimized compounds were demonstrated to be inverse agonists and compared in vivo with rimonabant for their ability to inhibit food intake, to occupy central CB1 receptors and to influence hormonal markers associated with obesity.
